Henry Schein (HSIC) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2026)
Henry Schein (HSIC) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Akso Health |
2,315,158.81 Bn |
2,315,158.63 Bn |
- |
- |
| 2 |
Mckesson |
92.76 Bn |
89.18 Bn |
4.04 Bn |
37.60% |
| 3 |
Cencora |
52.82 Bn |
50.83 Bn |
3.59 Bn |
128.26% |
| 4 |
Cardinal Health |
52.17 Bn |
48.39 Bn |
2.50 Bn |
-19.52% |
| 5 |
Henry Schein |
9.19 Bn |
9.71 Bn |
1.07 Bn |
4.55% |
| 6 |
Accendra Health |
246.88 Mn |
-90.00 Mn |
312.39 Mn |
-60.00% |
| 7 |
Edap Tms |
161.92 Mn |
146.92 Mn |
8.15 Mn |
-20.00% |
| 8 |
111 |
107.47 Mn |
25.61 Mn |
23.58 Mn |
-400.00% |
| 9 |
Cosmos Health |
9.42 Mn |
7.26 Mn |
1.38 Mn |
-100.00% |
| 10 |
Cellyan Biotechnology |
5.69 |
-2.48 Mn |
- |
- |
| Date | Value |
|---|
| Mar 28, 2026 |
4.55% |
| Dec 27, 2025 |
13.33% |
| Sep 27, 2025 |
7.69% |
| Jun 28, 2025 |
-12.50% |
| Mar 29, 2025 |
22.22% |
| Dec 28, 2024 |
435.71% |
| Sep 28, 2024 |
-25.71% |
| Jun 29, 2024 |
-24.53% |
| Mar 30, 2024 |
-20.88% |
| Dec 30, 2023 |
-61.11% |
| Sep 30, 2023 |
-3.67% |
| Jul 1, 2023 |
-8.62% |
| Apr 1, 2023 |
-30.00% |
| Dec 31, 2022 |
-65.71% |
| Sep 24, 2022 |
-5.22% |
| Jun 25, 2022 |
5.45% |
| Mar 26, 2022 |
12.07% |
| Dec 25, 2021 |
6.06% |
| Sep 25, 2021 |
16.16% |
| Jun 26, 2021 |
1,475.00% |
